Article Information
History
- April 15, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Hana Krismawati1,*,
- Astrid Irwanto2,*,
- Arry Pongtiku3,
- Ishak Darryl Irwan2,
- Yustinus Maldan1,
- Yuli Arisanti Sitanggang1,
- Tri Wahyuni1,
- Ratna Tanjung1,
- Yonghu Sun4,
- Hong Liu4,
- Furen Zhang4,
- Antonius Oktavian1 and
- Jianjun Liu, PhD2,†
- 1Institute of Research and Development for Biomedicine Papua, National Institute of Health Research and Development, Ministry of Health Republic of Indonesia
- 2Human Genetics, Genome Institute of Singapore, Agency for Science, Technology and Research, Singapore
- 3Faculty of Public Health Medicine, University of Cendrawasih Papua; Netherlands Leprosy Relief Indonesia
- 4Shandong Provincial Institute of Dermatology and Venereology & Provincial Hospital for Skin Diseases, Shandong First Medical University & Shandong Academy for Medical Sciences, Jinan, Shandong
- ↵†Corresponding Author:
Jianjun Liu, PhD, Group Leader, Human Genetics 2, Genome Institute of Singapore, Agency for Science, Technology and Research, Address: 60 Biopolis Street, #02-01, Genome, Singapore 138672, Email: liuj3{at}gis.a-star.edu.sg, Contact No: +65-68088088
↵* Denotes equal contribution
Posted April 15, 2020.
Validation Study of HLA-B*13:01 as a Biomarker of Dapsone Hypersensitivity Syndrome in Leprosy Patients in Indonesia
